Liver Function Tests
Also known as LFTs · ALT · AST · ALP
Blood tests measuring hepatic enzymes (ALT, AST, ALP) and bilirubin — reviewed before starting protocols with liver exposure.
Definition
Liver function tests quantify hepatocyte health via alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and bilirubin. Elevated ALT/AST suggests hepatocellular stress; elevated ALP points to biliary or bone pathology. Meto's clinicians include LFTs in the Peptide Readiness Panel and re-check at month 3 on any protocol with hepatic metabolism.
Read More
CMPComprehensive Metabolic Panel
A 14-marker blood panel measuring glucose, electrolytes, kidney and liver function — standard safety work before most protocols.
BiomarkerBiomarker
A measurable substance in blood, tissue or urine that reflects a biological state — the inputs your clinician uses to choose the right protocol.
BiomarkerPeptide Readiness Panel
Meto's $149 lab panel covering the biomarkers needed to match a patient to the right peptide protocol safely.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.